BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17509919)

  • 1. Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli.
    Jin YS; Stephanopoulos G
    Metab Eng; 2007 Jul; 9(4):337-47. PubMed ID: 17509919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes affecting lycopene accumulation in Escherichia coli using a shot-gun method.
    Kang MJ; Lee YM; Yoon SH; Kim JH; Ock SW; Jung KH; Shin YC; Keasling JD; Kim SW
    Biotechnol Bioeng; 2005 Sep; 91(5):636-42. PubMed ID: 15898075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli.
    Alper H; Jin YS; Moxley JF; Stephanopoulos G
    Metab Eng; 2005 May; 7(3):155-64. PubMed ID: 15885614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the gene knockout landscape for improved lycopene production in E. coli.
    Alper H; Stephanopoulos G
    Appl Microbiol Biotechnol; 2008 Apr; 78(5):801-10. PubMed ID: 18239914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced lycopene productivity by manipulation of carbon flow to isopentenyl diphosphate in Escherichia coli.
    Vadali RV; Fu Y; Bennett GN; San KY
    Biotechnol Prog; 2005; 21(5):1558-61. PubMed ID: 16209562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving NADPH availability for natural product biosynthesis in Escherichia coli by metabolic engineering.
    Chemler JA; Fowler ZL; McHugh KP; Koffas MA
    Metab Eng; 2010 Mar; 12(2):96-104. PubMed ID: 19628048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production.
    Kim SW; Keasling JD
    Biotechnol Bioeng; 2001 Feb; 72(4):408-15. PubMed ID: 11180061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal evolution of Escherichia coli for the efficient production of lycopene.
    Chen YY; Shen HJ; Cui YY; Chen SG; Weng ZM; Zhao M; Liu JZ
    BMC Biotechnol; 2013 Jan; 13():6. PubMed ID: 23356604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycopene production in recombinant strains of Escherichia coli is improved by knockout of the central carbon metabolism gene coding for glucose-6-phosphate dehydrogenase.
    Zhou Y; Nambou K; Wei L; Cao J; Imanaka T; Hua Q
    Biotechnol Lett; 2013 Dec; 35(12):2137-45. PubMed ID: 24062132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 IDI performs better than type 1 for improving lycopene production in metabolically engineered E. coli strains.
    Rad SA; Zahiri HS; Noghabi KA; Rajaei S; Heidari R; Mojallali L
    World J Microbiol Biotechnol; 2012 Jan; 28(1):313-21. PubMed ID: 22806807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets.
    Alper H; Miyaoku K; Stephanopoulos G
    Nat Biotechnol; 2005 May; 23(5):612-6. PubMed ID: 15821729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient production of Pseudoionone with multipathway engineering in Escherichia coli.
    Jiang R; Chen X; Lian J; Huang L; Cai J; Xu Z
    J Appl Microbiol; 2019 Jun; 126(6):1751-1760. PubMed ID: 30920693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of Escherichia coli for Lycopene Production Through Promoter Engineering.
    Shen HJ; Hu JJ; Li XR; Liu JZ
    Curr Pharm Biotechnol; 2015; 16(12):1094-103. PubMed ID: 26238682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate.
    Yoon SH; Lee YM; Kim JE; Lee SH; Lee JH; Kim JY; Jung KH; Shin YC; Keasling JD; Kim SW
    Biotechnol Bioeng; 2006 Aug; 94(6):1025-32. PubMed ID: 16547999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of lycopene by metabolically-engineered Escherichia coli.
    Sun T; Miao L; Li Q; Dai G; Lu F; Liu T; Zhang X; Ma Y
    Biotechnol Lett; 2014 Jul; 36(7):1515-22. PubMed ID: 24806808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Various
    Ren J; Shen J; Thai TD; Kim MG; Lee SH; Lim W; Na D
    J Microbiol Biotechnol; 2023 Jul; 33(7):973-979. PubMed ID: 37100763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of lycopene production by supplementing auxiliary carbon sources in metabolically engineered Escherichia coli.
    Kim YS; Lee JH; Kim NH; Yeom SJ; Kim SW; Oh DK
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):489-97. PubMed ID: 21246354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems analysis of methylerythritol-phosphate pathway flux in E. coli: insights into the role of oxidative stress and the validity of lycopene as an isoprenoid reporter metabolite.
    Bongers M; Chrysanthopoulos PK; Behrendorff JB; Hodson MP; Vickers CE; Nielsen LK
    Microb Cell Fact; 2015 Nov; 14():193. PubMed ID: 26610700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mutator genes and mutational pathways in Escherichia coli using a multicopy cloning approach.
    Yang H; Wolff E; Kim M; Diep A; Miller JH
    Mol Microbiol; 2004 Jul; 53(1):283-95. PubMed ID: 15225322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lycopene-overproducing E. coli strains in high cell density fermentations.
    Alper H; Miyaoku K; Stephanopoulos G
    Appl Microbiol Biotechnol; 2006 Oct; 72(5):968-74. PubMed ID: 16502313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.